investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

AMPHASTAR PHARMACEUTICALS IN
(03209R103)

Funds Reporting Holdings of AMPHASTAR PHARMACEUTICALS IN according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
Renaissance Technologies LLC 588,000 $12,413k Jun 30, 2019 Aug 12, 2019
Rothschild & Co Asset Management US Inc 347,523 $7,336k Jun 30, 2019 Jul 25, 2019
Cortina Asset Management LLC 261,771 $5,526k Jun 30, 2019 Jul 2, 2019
Argent Capital Management LLC 188,140 $3,972k Jun 30, 2019 Aug 15, 2019
Point72 Asset Management LP 162,286 $3,426k Jun 30, 2019 Aug 14, 2019
QS Investors LLC 72,447 $1,530k Jun 30, 2019 Aug 14, 2019
Prelude Capital Management LLC 5,935 $125k Jun 30, 2019 Aug 14, 2019
Acadian Asset Management LLC 4,200 $88k Jun 30, 2019 Aug 8, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.